COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,252 Articles (22,236 medRxiv, 8,016 bioRxiv)

Most recent first Previous |  Page 1064: Articles 10631-10640  | Next

Preclinical and clinical validation of a novel injected molded swab for molecular assay detection of SARS-CoV-2 virus
Ghezzi, C. E., Hartigan, D. R., Hardick, J., Gore, R., Adelfio, M., Diaz, A. R., McGuiness, P. D., Robinson, M. L., Buchholz, B. O., Manabe, Y. C. L.
10.1101/2021.10.19.21265200 — Posted: 2021-10-26
The Relationship Between Food Security and Dietary Patterns Status with COVID-19 in Northeastern Iran: Protocol for a Case-Control Study
Badri-Fariman, S., Pourghassem-Gargari, B., Badri-Fariman, M., Pourfridoni, M., Daneshi-Maskooni, M.
10.1101/2021.10.20.21265103 — Posted: 2021-10-26
Early COVID-related Acute Kidney Injury Recovery May Course with Hydroelectrolytic Disorders in Patients With High Risk of Insensible Fluid Loss
Braga Barbosa, G. S., de Jesus Torres de Melo, A. G., Gomes Ribeiro, R., del Pilar Via Reque Cortes, D., Sandoval Cabrera, C. P., Santos Andrade Filho, R., Tamborra Pantaroto, G., de Castro Paul Schultze, B., Paula, G. A., Rodrigues, C. E.
10.1101/2021.10.20.21265300 — Posted: 2021-10-26
Network analysis of England single parent household COVID-19 control policy impact; a proof-of-concept study
Edelman, N. L., Simon, P., Cassell, J. A., Kiss, I.
10.1101/2021.10.26.21265363 — Posted: 2021-10-26
REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT
KR, R., Rathod, C., Darnule, R., Loganathan, S., Deodhar, S., A, R., Marwah, A., Chaudhari, N. M., Thakur, B. K., Vaidyanathan, S., Athalye, S. N.
10.1101/2021.10.25.21265462 — Posted: 2021-10-26
Outbreak of SARS-CoV-2 B.1.617.2 (Delta) variant in a Nursing Home 28 weeks after two doses of mRNA anti-Covid-19 vaccines: evidence of a waning immunity
Pierobon, A., Dal Zotto, A., Antico, A., De Antoni, M. E., Vianello, L., Gennari, M., Di Caprio, A., Russo, F., Brambilla, G., Saugo, M.
10.1101/2021.10.25.21265370 — Posted: 2021-10-26
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy
Hussey, H., Davies, M.-A., Heekes, A., Williamson, C., Valley-Omar, Z., Hardie, D. R., Korsman, S., Doolabh, D., Preiser, W., Maponga, T., Iranzadeh, A., Wasserman, S., Schrueder, N., Boloko, L., Raubenheimer, P., Symons, G., Parker, A., Viljoen, A., Cohen, C., JASSAT, W., Lessels, R., Wilkinson, R. J., Boulle, A., Hsiao, N.-y. M.
10.1101/2021.10.23.21265412 — Posted: 2021-10-26
Predicting willingness to be vaccinated for Covid-19: evidence from New Zealand
Kaine, G., Wright, V., Greenhalgh, S.
10.1101/2021.10.24.21265447 — Posted: 2021-10-26
Occupational versus community risk of SARS-CoV-2 infection among employees of a long-term care facility: an observational study
Lenggenhager, L., Martischang, R., Sauser, J., Perez, M., Vieux, L., Graf, C., Cordey, S., Laubscher, F., Robalo Nunes, T., Zingg, W., Cori, A., Harbarth, S., Abbas, M.
10.1101/2021.10.22.21265309 — Posted: 2021-10-26
Access and quality of sexual and reproductive health (SRH) services in Britain during the early stages of the COVID-19 pandemic: a qualitative interview study of patient experiences
Boso Perez, R., Reid, D., Maxwell, K. J., Gibbs, J., Dema, E., Bonell, C., Mercer, C. H., Sonnenberg, P., Field, N., Mitchell, K. R.
10.1101/2021.10.22.21264941 — Posted: 2021-10-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).